Tag Archives: zacks funds

4 Commodity Currency ETFs Outshining Dollar To Start Q4

The China-induced global economic uncertainties lashed out on the most risky asset classes to close Q3 and restrained the Fed from hiking key interest rates almost after a decade. Though the Fed attributed a wavering global financial market and a subdued inflation profile as the main cause for the deterrence of a lift-off, the sailing wasn’t smooth at home too. This was because the U.S. economy reported sub-par jobs data in September. The year-to-date monthly pace of job gains now averages 198K and the pace for the last three months was much lower at 167K. This compares with the monthly average of 260K for 2014. A weaker jobs report crushed all chances of a sooner-than-expected rate hike in the U.S., as it points toward slowing U.S. growth momentum. As a result, this latest bit of employment information stabbed the strength of the greenback which ruled the currency world for over a year and did magic for most commodities and the related ETFs to start of the fourth quarter. Dollar ETF PowerShares DB US Dollar Bullish ETF (NYSEARCA: UUP ) lost about 1.5% in the last 10 days (as of October 9, 2015) while most commodity-centric currencies turned out as surprise winners. Apart from the range-bound U.S. dollar, an oil price rebound following falling crude oil production, the commodities behemoth Glencore PLC’s ( OTCPK:GLCNF ) ( OTCPK:GLNCY ) announcement to close its supply of many actively traded commodities from zinc to copper and a slowly stabilizing Chinese market (which happens to be a foremost user of metals) boosted trading in commodities. Prior to this, commodities witnessed horrendous trading and it goes without saying that such huge and prolonged sell-offs have made the commodities’ valuation so cheap that any single driver would easily take the commodity currency ETFs to new heights. Though we believe the trend might tumble once the rising rate worries are back on the table, at the current level many investors may try to remove some of the dollar risk from their portfolio and focus on currency ETFs that are outdoing the dollar to start Q4: Below, we highlight four such currency funds that are shooting ahead of the greenback in October: WisdomTree Brazilian Real Strategy Fund (NYSEARCA: BZF ) – Up 6.1% Brazilian real was at a two-decade low at the end of September. But central bank intervention, easing political dispute over the budget, a subsiding lift-off and a commodity market bounce added to the real strength to start Q4. Since, Brazil is a commodity-centric economy, the recent surge in real is self-explanatory. Brazil’s Congress okayed most of the budget cuts, pension reforms and tax hikes planned by Rousseff’s government to contain spending and limit above-goal inflation. This fund seeks to achieve total returns reflective of both money market rates in Brazil available to foreign investors and changes in value of the Brazilian real relative to the U.S. dollar. Both AUM and average daily volume are paltry at $15.4 million and 20,000 shares, respectively. The product charges 45 bps in annual fees and is down 23.1% so far this year (as of October 9, 2015). It has a Zacks ETF Rank of 5 or ‘Strong Sell’ rating with a High risk outlook. However, the fund added over 6.1% in the last 10 days. WisdomTree Commodity Currency Fund (NYSEARCA: CCX ) – Up 4.5% This fund provides investors exposure to the currencies and money market rates of countries commonly known as commodity exporters. It seeks to achieve total returns reflective of both money market rates in select commodity-producing countries available to foreign investors and changes to the value of these currencies relative to the U.S. dollar. With this approach, investors can embark upon a variety of economies around the world. The product invests in eight currencies – Australian Dollar, Brazilian Real, Canadian Dollar, Chilean Peso, Norwegian Krone, New Zealand Dollar, Russian Ruble, and South African Rand – almost in equal proportions. The fund is often overlooked by investors as depicted by its AUM of just $6.3 billion and average daily volume of about 1,500 shares. It charges 55 bps in annual fees. The ETF was up 4.5% over the past 10 days. WisdomTree Dreyfus Emerging Currency Fund (NYSEARCA: CEW ) – Up 4.8% Thanks to the commodity strength, even emerging market currencies took the lead. Currently, the fund has a focus on Asian currencies (42%), followed by Latin America (25%) and Europe (17%). This currency ETF also sees solid volume of about 45,000 shares a day on comparable $57.1 million in AUM. CEW charges 55 bps in fees. CEW advanced about 4.8% in the last 10 days (as of October 9, 2015). Guggenheim CurrencyShares Australian Dollar Trust ETF (NYSEARCA: FXA ) – Up 4.3% This fund offers a great play to capitalize on the future rise in the Australian dollar relative to the U.S. dollar. It tracks the movement of the Australian dollar relative to the USD, net of the Trust expenses, which are expected to be paid from the interest earned on the deposited Australian dollars. The product has amassed $180.1 million in its asset base while trades in moderate volume of 45,000 shares per day on average. It has an expense ratio of 0.40% and was up 4.3% over the past 10 days. Original post .

5 Top-Rated Healthcare Mutual Funds To Add To Your Portfolio

Healthcare mutual funds provide excellent choices for investors looking to enter this safe-haven sector, which is likely to protect their investment during a market downturn. The healthcare sector has proven to be one of the most desirable avenues during difficult times as it does not vary with market conditions. Also, several pharmaceutical companies have a history of paying regular dividends, which can help to offset the losses from plummeting share prices. Below we will share with you 5 top-ranked healthcare mutual funds. Each has earned a Zacks #1 Rank (Strong Buy) as we expect these mutual funds to outperform their peers in the future. Fidelity Select Health Care Portfolio (MUTF: FSPHX ) seeks capital growth over the long run. FSPHX invests a major portion of its assets in companies involved in designing, manufacturing and selling healthcare products and services. FSPHX invests in companies across the world. The Fidelity Select Health Care Portfolio is a non-diversified fund and has returned 10.6% over the past one year. FSPHX has an expense ratio of 0.74% as compared to a category average of 1.35%. Fidelity Select Biotechnology Portfolio (MUTF: FBIOX ) invests a large share of its assets in companies primarily involved in research, development, manufacture and distribution of various biotechnological products. Factors such as financial strength and economic conditions are considered to invest in companies located anywhere in the world. The Fidelity Select Biotechnology Portfolio is a non-diversified fund and has returned 22.7% over the past one year. Rajiv Kaul is the fund manager and has managed FBIOX since 2005. Turner Medical Sciences Long/Short C (MUTF: TMSCX ) seeks capital appreciation. TMSCX invests a major chunk of its assets in healthcare firms. TMSCX uses a long/short growth strategy for reduction of volatility and capital preservation during a market downturn. TMSCX mainly focuses on acquiring securities of companies having market capitalizations greater than $250 million. TMSCX is expected to maintain a portfolio of 15 to 75 securities long, and 15 to 75 securities short. The Turner Medical Sciences Long/Short C has returned 11.1% over the past one year. TMSCX has an expense ratio of 1.50% as compared to a category average of 1.84%. Fidelity Select Medical Delivery Portfolio (MUTF: FSHCX ) invests largely in companies that either own or are involved in operating hospital and nursing homes, and are related to the healthcare services sector. FSHCX focuses on acquiring common stocks of both US and non-US companies. The Fidelity Select Medical Delivery Portfolio fund is non-diversified and has returned 19.9% over the last one-year period. Steven Bullock is the fund manager and has managed FSHCX since 2012. Fidelity Select Medical Equipment & Systems (MUTF: FSMEX ) seeks capital growth. FSMEX invests the majority of its assets in companies that are primarily involved in medical equipment and devices and the related technologies sector. FSMEX focuses on acquiring common stocks of companies by analyzing factors including financial strength and economic condition. FSMEX invests in both US and non-US companies. The Fidelity Select Medical Equipment & Systems is a non-diversified fund and has returned almost 14.3% over the past one year. As of August 2015, FSMEX held 55 issues with 23.57% of its assets invested in Medtronic PLC. Original Post

5 Ways To Play The Oil Rebound With ETFs

After a bumpy ride, oil regained its momentum with the start of the fourth quarter, indicating that the worst might be over for the commodity. All credit goes to improving demand/supply dynamics, which are rebuilding the lost confidence in the rebalancing of the oil market. This is especially true as Nymex crude is now comfortably hovering around the key threshold $50 per barrel, having gained 11% since the start of October, while Brent oil jumped 10.4%. Improving Fundamentals The steep gains came on the heels of dwindling supply, improving demand and an increased willingness by major oil producers to support the prolonged slump in the market. In particular, production in the U.S. and non-OPEC countries is declining, while global demand is increasing. U.S. oil output is expected to decline from 9.25 million barrels per day (bpd) in 2015 to 8.86 million bpd in 2016, while non-OPEC production will likely fall by 0.5 million bpd next year, the sharpest drop in more than two decades. The Energy Information Administration (EIA) expects global oil demand for 2016 to increase at the fastest pace in six years, suggesting that oversupply is easing faster than expected. Overall, the OPEC Secretary General, Abdalla Salem El-Badri, projects the oil market to be more balanced next year, as the gap in crude oil supply and demand will likely close in the third quarter of 2016. He foresees global demand to grow to 110 million bpd by 2040, from the current 93 million bpd. On the other hand, Qatar’s energy minister, Mohammed Al Sada, expects oil prices to have bottomed out and supplies from non-OPEC countries to turn negative next year, and the demand to rise to 30.5 million bpd from 29.3 million bpd in 2015. Further, a declining rig count and the weakening dollar of late are adding to the strength. Given the renewed optimism and signs that the oil market may begin to tighten, many investors have turned bullish and are seeking to tap this opportunity. For them, there are two ways to play this surge – one by directly playing through the futures contracts, and the other through equities. Equity ETFs Beating Futures Out of the two ways, equities are leading the current oil rally, given that the ultra-popular United States Oil ETF (NYSEARCA: USO ), providing exposure to the Nymex crude, gained 8.9% since the start of October, while an equity-based ETF like the Energy Select Sector SPDR ETF (NYSEARCA: XLE ) is up 12.6%. This is because revenues and earnings of oil producers are closely tied to oil prices. Acting as a leveraged play, oil stocks tend to experience more gains or losses than oil itself in a rising or falling commodity market. As a result, equity-based oil ETFs will continue to be the real winners in the weeks ahead if oil price continues to rise. Investors can definitely look into the leveraged products in this space for outsized returns. Notably, leveraged ETFs could lead to huge gains in a very short time frame as compared to the simple products. Below, we have highlighted five equity-based leveraged ETFs that could be excellent picks for investors seeking to make large profits from the Energy space in a short span (see: all Leveraged Equity ETFs here ): Direxion Daily Energy Bull 3x Shares ETF (NYSEARCA: ERX ) This fund creates a triple (3x, or 300%) leveraged long position in the S&P Energy Select Sector Index, while charging 95 bps in fees a year. It is a popular and liquid option in the Energy leveraged space, with AUM of $557.2 million and average trading volume of 2.3 million shares. The ETF gained over 41% since the start of October. ProShares Ultra Oil & Gas ETF (NYSEARCA: DIG ) This ETF seeks to deliver twice (2x, or 200%) the daily performance of the Dow Jones U.S. Oil & Gas Index. It has been able to manage $153.4 million in its asset base, with trades in a good volume of more than 186,000 shares per day, on average. The product is up 26.7% in the same time frame. Direxion Daily Natural Gas Related Bull 3x Shares ETF (NYSEARCA: GASL ) This product seeks to deliver thrice the daily performance of the ISE Revere Natural Gas Index, which derives a substantial portion of its revenues from the exploration and production of natural gas. The fund is often overlooked by the investors, as depicted by its AUM of $63.7 million and average daily trading of 161,000 shares. Its expense ratio comes in at 0.95%. The fund has delivered whopping returns of 104.1% since the start of October. Direxion Daily S&P Oil & Gas Exploration & Production Bull 3x Shares ETF (NYSEARCA: GUSH ) This fund offers triple exposure to the daily performance of the S&P Oil & Gas Exploration & Production Select Industry Index. It debuted in the space only four months ago, and has accumulated $10 million in its asset base. The average daily volume is low at around 58,000 shares, while its expense ratio is 0.95%. The product has gained 74.6% in the same time frame. ProShares Ultra Oil & Gas Exploration & Production ETF (NYSEARCA: UOP ) This product also tracks the S&P Oil & Gas Exploration & Production Select Industry Index, but offers twice the returns of the daily performance with the same expense ratio as that of GUSH. It has AUM of just $2 million, and trades in a paltry volume of 1,000 shares. UOP is up over 49% so far this month. Bottom Line As a caveat, investors should note that these products are extremely volatile and suitable only for short-term traders. Additionally, the daily rebalancing, when combined with leverage, may make these products deviate significantly from the expected long-term performance figures. Still, for ETF investors who are bullish on oil for the near term, either of the above products can be an interesting choice. Clearly, a near-term long could be intriguing for those with high-risk tolerance, and a belief that the “trend is the friend” in this corner of the investing world. Original Post